DuoGenic was founded on March 22, 2018, in order to provide highly-efficient, standardized and popular stem cells, besides their culture platforms. Our team consists of enthusiastic researchers familiar with stem cell culture techniques. DuoGenic also possesses strong clinical supports, and is now devoted to the development and the manufacture of stem cell culture media. Furthermore, based on the current basic research, we aim at establishing a mass production system of 2D and 3D culture media, as well as worldwide stem cell culture technique services. Meanwhile, we also dedicate ourselves to develop culture media solutions for clinical cell therapies.